Related Experiment Video
Updated: Jun 11, 2025

10:30
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
Published on: May 16, 2015
19.6K
Summary
Neonatal hypoglycemia in infants of diabetic mothers requires prompt intervention. This case highlights extremely low blood glucose and high insulin levels, successfully managed with glucose infusion, emphasizing close monitoring for healthy development.
Area of Science:
- Neonatalogy
- Endocrinology
- Pediatrics
Background:
- Neonatal hypoglycemia lacks a unified definition, typically diagnosed below 2.2 mmol/L blood glucose.
- Infants of Diabetic Mothers (IDMs) are at high risk for hypoglycemia due to maternal diabetes.
- This case report addresses extreme neonatal hypoglycemia in an IDM, emphasizing monitoring and intervention.
Observation:
- A newborn from a diabetic mother presented with extremely low blood glucose levels immediately after birth.
- Maternal pre-delivery glucose was 8.28 mmol/L; newborn's initial blood glucose was 2.6 mmol/L, serum glucose 0.11 mmol/L.
- Elevated newborn insulin (805.55 pmol/L) and C-peptide (2,312.64 pmol/L) were noted, with maternal HbA1c at 7.5%.
Findings:
- The neonate received intravenous 10% glucose, initially at 12.7 mL/d, then bolus infusion at 7.7 mL/minute for 30 minutes.
- Blood glucose levels were successfully raised to a stable 5.2 mmol/L.
- The intervention effectively managed the critically low blood glucose in the IDM.
Implications:
- Maternal diabetes significantly impacts newborns, necessitating vigilant monitoring.
- Timely glucose level management is crucial for preventing neonatal complications.
- Early intervention in IDMs promotes long-term healthy growth and development.
Related Concept Videos
Hypoglycemia and Glucagon
164
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
164
Pathophysiology of Diabetes
881
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
881

